Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Comment by Giverbulletson Sep 14, 2011 12:23am

324 Views

Post# 19039792

RE: RE: Not GPD but interesting!

I agree, GPD is teaming with money and has everything I'm looking for, but I have never seen such dense gold streams before like the ones coming from BGM. Would these dense streams not represent something much bigger in the local area? Or are these numbers just not that extraordinary?

Back to GPD, though, having cash on hand to run to the end of next year is just awesome. Getting a gold loan for the mine that can be paid back in a year......even better, no more dilution, only some 2012 warrants left., 43-101's coming this year......why the hell are people still selling this!!!!?

Giver

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features